Skip to main content
. 2010 Dec;8(Suppl 1):S-15–S-21. doi: 10.1089/met.2010.0095

Table 5.

Categories Based on Major Site of Action

Insulin resistance
 Biguanides: metformin
 Thiazolidinediones (TZD): pioglitazone, rosiglitazone
Islet-cell dysfunction
 Sulfonylureas (SU)/meglitinides
 GLP-1 agonists: exenatide, liraglutide
 DPP-4 inhibitors: sitaglipitin, saxaglitin
Gastointestinal tract
 Alpha-glucosidase inhibitors: acarbose, miglitol
 Bile acid sequestrants (BAS): cholestyramine, colesevelam

GLP-1, glucagon-like peptide-1; DPP-4, dipeptidyl peptidase-4.